A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample.

Autor:	Klyn NAM; Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA., Kleindienst Robler S; Division of Audiology, Mayo Clinic, Scottsdale, Arizona, USA.; Department of Audiology, Norton Sound Health Corporation, Nome, Alaska, USA., Alfakir R; Department of Otorhinolaryngology, Mayo Clinic, Jacksonville, Florida, USA., Nielsen DW; Don Nielsen Consulting, LLC, Dublin, Ohio, USA., Griffith JW; Department of Medical Social Science, Northwestern University, Chicago, Illinois, USA., Carlson DL; Department of Otolaryngology, University of Texas Medical Branch, Galveston, Texas, USA., Lundy L; Department of Otorhinolaryngology, Mayo Clinic, Jacksonville, Florida, USA., Dhar S; Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA.; The Hugh Knowles Center, Northwestern University, Evanston, Illinois, USA., Zapala DA; Department of Otorhinolaryngology, Mayo Clinic, Jacksonville, Florida, USA.
Jazyk:	angličtina
Zdroj:	Ear and hearing [Ear Hear] 2018 Sep-Oct; Vol. 39 (5), pp. 1035-1038.
DOI:	10.1097/AUD.0000000000000561
Abstrakt:	Objectives: The purpose of this study was to evaluate the specificity and sensitivity of two red flag protocols in detecting ear diseases associated with changes in hearing. Design: The presence of red-flag symptoms was determined in a chart review of 307 adult patients from the Mayo Clinic Florida Departments of Otorhinolaryngology and Audiology. Participants formed a convenience sample recruited for a separate study. Neurotologist diagnosis was the criterion for comparisons. Results: Of the 251 patient files retained for analysis, 191 had one or more targeted diseases and 60 had age- or noise-related hearing loss. Food and Drug Administration red flags sensitivity was 91% (confidence interval [CI], 86 to 95%) and specificity was 72% (CI, 59 to 83%). American Academy of Otolaryngology-Head and Neck Surgery red flags sensitivity was 98% (CI, 95 to 99%) and specificity was 20% (CI, 11 to 32%). Conclusions: Stakeholders must determine which diseases are meaningful contraindications for hearing aid use and whether these red-flag protocols have acceptable levels of sensitivity and specificity. As direct-to-consumer models of hearing devices increase, a disease detection method that does not require provider intercession would be useful.
Databáze:	MEDLINE
Externí odkaz: